Skandinaviska Enskilda Banken (SEB)’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-377,806
| Closed | -$25.1M | – | 330 |
|
|
2025
Q4 | $25.1M | Buy |
377,806
+89,743
| +31% | +$5.8M | 0.1% | 156 |
|
|
2025
Q3 | $19.4M | Sell |
288,063
-4,196
| -1% | -$332K | 0.08% | 190 |
|
|
2025
Q2 | $25.5M | Buy |
292,259
+696
| +0.2% | +$54.6K | 0.11% | 155 |
|
|
2025
Q1 | $19.9M | Buy |
291,563
+7,909
| +3% | +$645K | 0.1% | 172 |
|
|
2024
Q4 | $22.1M | Buy |
283,654
+9,668
| +4% | +$716K | 0.1% | 166 |
|
|
2024
Q3 | $18.4M | Sell |
273,986
-2,110
| -0.8% | -$173K | 0.08% | 189 |
|
|
2024
Q2 | $31.3M | Sell |
276,096
-43,538
| -14% | -$5.5M | 0.15% | 114 |
|
|
2024
Q1 | $44.3M | Sell |
319,634
-13,762
| -4% | -$1.73M | 0.22% | 85 |
|
|
2023
Q4 | $41.4M | Buy |
333,396
+84,448
| +34% | +$8.63M | 0.24% | 80 |
|
|
2023
Q3 | $23.2M | Buy |
248,948
+172,313
| +225% | +$19.4M | 0.15% | 139 |
|
|
2023
Q2 | $9.85M | Buy |
76,635
+6,088
| +9% | +$736K | 0.06% | 266 |
|
|
2023
Q1 | $8.2M | Sell |
70,547
-1,322
| -2% | -$148K | 0.06% | 292 |
|
|
2022
Q4 | $8.14M | Buy |
71,869
+3,607
| +5% | +$396K | 0.06% | 282 |
|
|
2022
Q3 | $5.5M | Sell |
68,262
-8,487
| -11% | -$719K | 0.04% | 339 |
|
|
2022
Q2 | $5.72M | Sell |
76,749
-9,755
| -11% | -$890K | 0.04% | 343 |
|
|
2022
Q1 | $11.1M | Sell |
86,504
-140,920
| -62% | -$15.4M | 0.06% | 260 |
|
|
2021
Q4 | $30.8M | Sell |
227,424
-85,940
| -27% | -$12.3M | 0.16% | 128 |
|
|
2021
Q3 | $42.8M | Buy |
313,364
+75,080
| +32% | +$9.47M | 0.23% | 99 |
|
|
2021
Q2 | $25.4M | Buy |
238,284
+140,100
| +143% | +$13.5M | 0.16% | 141 |
|
|
2021
Q1 | $8.82M | Buy |
98,184
+8,084
| +9% | +$759K | 0.06% | 288 |
|
|
2020
Q4 | $8.33M | Sell |
90,100
-62,476
| -41% | -$5.58M | 0.06% | 274 |
|
|
2020
Q3 | $15.7M | Buy |
152,576
+18,028
| +13% | +$1.88M | 0.11% | 170 |
|
|
2020
Q2 | $13.6M | Buy |
134,548
+75,436
| +128% | +$6.75M | 0.11% | 177 |
|
|
2020
Q1 | $3.98M | Sell |
59,112
-6,188
| -9% | -$385K | 0.04% | 317 |
|
|
2019
Q4 | $3.57M | Buy |
65,300
+8,960
| +16% | +$425K | 0.03% | 420 |
|
|
2019
Q3 | $2.1M | Sell |
56,340
-2,000
| -3% | -$77.7K | 0.02% | 525 |
|
|
2019
Q2 | $2.19M | Buy |
58,340
+2,488
| +4% | +$78.2K | 0.02% | 485 |
|
|
2019
Q1 | $1.66M | Buy |
55,852
+9,852
| +21% | +$346K | 0.02% | 506 |
|
|
2018
Q4 | $1.38M | Buy |
+46,000
| New | +$1.46M | 0.01% | 574 |
|
|
2017
Q4 | – | Sell |
-44,116
| Closed | -$540K | – | 714 |
|
|
2017
Q3 | $540K | Hold |
44,116
| – | – | ﹤0.01% | 654 |
|
|
2017
Q2 | $807K | Hold |
44,116
| – | – | 0.01% | 639 |
|
|
2017
Q1 | $934K | Buy |
44,116
+28,116
| +176% | +$549K | 0.01% | 629 |
|
|
2016
Q4 | $239K | Buy |
+16,000
| New | +$283K | ﹤0.01% | 619 |
|
Other funds holding DXCM
Skandinaviska Enskilda Banken (SEB)'s DXCM Position: Q1 2026 in Review
Skandinaviska Enskilda Banken (SEB) sold out of DexCom (DXCM) in Q1 2026, closing a stake of 377,806 shares — an estimated $25.1M sold.
Skandinaviska Enskilda Banken (SEB) first reported a position in DXCM in Q4 2016 and held it in 33 quarters. The position peaked at $44.3M in Q1 2024. 960 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.
- Skandinaviska Enskilda Banken (SEB) reported no remaining DexCom position as of Q1 2026 after selling out during the quarter.
- Skandinaviska Enskilda Banken (SEB) sold 377,806 DexCom shares in Q1 2026, an estimated $25.1M.
- Skandinaviska Enskilda Banken (SEB) first reported a position in DexCom in Q4 2016 and held it in 33 quarters.
- Skandinaviska Enskilda Banken (SEB)'s DexCom position peaked at $44.3M in Q1 2024.
- 960 funds tracked by Wall St. Rank held DexCom as of Q1 2026.
Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q1 2026, filed 15 May 2026.